Developing translatable technologies that promote bone regeneration and spinal fusion more efficiently and safely.
The research team led by bone biologist, Erin Hsu, and orthopaedic surgeon, Wellington Hsu, focuses on developing novel biomaterials for bone regeneration. The approaches and technologies they utilize include stem cell-based therapies, nanotechnology-based synthetic matrices, and osteoinductive 3D-printable natural and synthetic materials.
With a particular pre-clinical focus on spine, our goal is to develop translatable technologies that promote bone regeneration and spinal fusion and explores the inhibitory mechanisms of action of environmental chemicals on bone.
